Jamie N Anastas

6PUBLICATIONS

98CO-AUTHORS

Epigenetics (incl. genome methylation and epigenomics)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (6)

Sort by Publication Date:

|Jun 04, 2026

Elongin B orchestrates chromatin and transcriptional programs in H3K27M-mutant diffuse midline glioma.

|Apr 17, 2026

H3 dopaminylation and CaMKII modulate diffuse midline glioma response to CDK9 inhibition.

|Feb 06, 2026

SAGA/ATAC complexes sustain aberrant chromatin regulation and promote tumorigenesis in diffuse midline glioma.

Rosemary U Richard, Caitlin Bagnetto, Rebecca L Murdaugh

|May 21, 2024

Phase I Trial of GD2.CART Cells Augmented With Constitutive Interleukin-7 Receptor for Treatment of High-Grade Pediatric CNS Tumors.

Frank Y Lin, Austin Stuckert, Candise Tat

|Sep 11, 2023

<i>SOD1</i> is a synthetic lethal target in <i>PPM1D</i>-mutant leukemia cells.

Linda Zhang, Joanne I Hsu, Etienne D Braekeleer

|Oct 28, 2022

BAF Complex Maintains Glioma Stem Cells in Pediatric H3K27M Glioma.

Eshini Panditharatna, Joana G Marques, Tingjian Wang

Pageof 1

Frequent Collaborators

Rebecca L Murdaugh

Brittany R Eberl

Akdes Serin-Harmanci

Alan L Jiao

Kwanha Yu

Barry M Zee

Caitlin L Bagnetto

Mariella G Filbin

Zhuyong Mei

Meghan Shekar

Frequent Collaborators

Rebecca L Murdaugh

Brittany R Eberl

Akdes Serin-Harmanci

Alan L Jiao